The Problem: Underuse of Generic Drugs
With up to $2.7 Trillion spent annually on healthcare, you need a clear understanding of cost, quality and utilization to help reduce your costs. A recent study by the NEHI showed a $3 Billion savings opportunity for a given population by converting from brand-label to generic antihypertensives. Solutions like our Enterprise Intelligence will help cut through the clutter and minimize your program inefficiencies.
Savings from switching to equally effective, generic hypertensives
The total active participants currently in Taft Hartley Funds